Actively Recruiting
Renal Function After Stentgraft Treatment Of Abdominal Aortic Aneurysm
Led by Vastra Gotaland Region · Updated on 2024-05-07
252
Participants Needed
1
Research Sites
258 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This randomized controlled trial aim to determine the impact on renal function after treatment for infrarenal abdominal aortic aneurysm (AAA) with stentgrafts either with active supra- or infrarenal fixation.
CONDITIONS
Official Title
Renal Function After Stentgraft Treatment Of Abdominal Aortic Aneurysm
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Willing and able to provide written informed consent
- Have a non-ruptured infrarenal or iliac abdominal aortic aneurysm
- Have anatomy suitable for treatment with an approved stentgraft device for AAA
- Accepted for treatment with endovascular aortic repair (EVAR) by the participating vascular center
You will not qualify if you...
- Currently on dialysis or planning to start dialysis
- Need AAA treatment involving stents or stentgrafts in the renal or visceral arteries
- Unable to complete health-related quality of life questionnaires due to language barriers
- Anatomical issues preventing use of both fixation types, such as severe suprarenal tortuosity (>60 degrees), advanced suprarenal dilation, or infrarenal thrombus >25% of circumference
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Sahlgrenska University Hospital
Gothenburg, VastraGotaland, Sweden
Actively Recruiting
Research Team
P
Per Skoog, M.D
CONTACT
J
Joakim Nordanstig, M.D
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here